Overview
Nancy Peacock is an Oncologist in Franklin, Tennessee. Dr. Peacock is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, HER-2 Positive Breast Cancer, and Inflammatory Breast Cancer. Dr. Peacock is currently accepting new patients.
Her clinical research consists of co-authoring 10 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- MEDICARE MAPD
- MEDICARE PDP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
9040 Carothers Pkwy, Suite A205, Franklin, TN 37067
1750 Cedar Ln, Suite 200, Tullahoma, TN 37388
300 20th Ave N, Suite 301, Nashville, TN 37203
250 25th Ave N, Nashville, TN 37203
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Tennessee Oncology PLLC
Ian Flinn is a Hematologist Oncology specialist and a Hematologist in Tullahoma, Tennessee. Dr. Flinn is rated as an Elite provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Flinn is currently accepting new patients.
Sarah Cannon Research Institute
Dr. Patel joined SCRI in 2024, as director of lymphoma research, and oversees SCRI’s comprehensive lymphoma clinical trial portfolio. Previously, he served as the Director of Hematologic Malignancies and Cell Therapy at the Swedish Cancer Institute in Seattle, Washington, where he led development of the program’s clinical standards for lymphoma care, assisted in the expansion of cell therapy services, and helped shape lymphoma research efforts. Dr. Patel was also a member of the Paul G. Allen Research Center at Seattle Cancer Institute, serving as a co-founding member of the Center for Immuno-oncology, where he collaborated on translational research related to immunotherapy in hematologic diseases.Dr. Patel has been published in various medical journals, including New England Journal of Medicine, Blood, and Journal of Clinical Oncology. He is also a member of the ASCO Cancer Communications Committee, the CIBMTR Lymphoma Working Committee, and the National Planning Committee for the Lymphoma Research Foundation Lymphoma Rounds. His clinical and research focus is in lymphomas, CLL, and cellular therapy. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Vanderbilt Health Clinicians, LLC
David Morgan is a Hematologist Oncology specialist and an Oncologist in Nashville, Tennessee. Dr. Morgan is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Small Lymphocytic Lymphoma (SLL), and Bone Marrow Aspiration. Dr. Morgan is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Peacock isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Peacock isDistinguished. Learn about Breast Cancer.
- HER-2 Positive Breast CancerDr. Peacock isDistinguished. Learn about HER-2 Positive Breast Cancer.
- Inflammatory Breast CancerDr. Peacock isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Peacock isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Acute Promyelocytic LeukemiaDr. Peacock isAdvanced. Learn about Acute Promyelocytic Leukemia.
- AgranulocytosisDr. Peacock isAdvanced. Learn about Agranulocytosis.
- Chronic Familial NeutropeniaDr. Peacock isAdvanced. Learn about Chronic Familial Neutropenia.
- Lung CancerDr. Peacock isAdvanced. Learn about Lung Cancer.
- Multiple MyelomaDr. Peacock isAdvanced. Learn about Multiple Myeloma.
- Pleuropulmonary BlastomaDr. Peacock isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Peacock isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Peacock isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Peacock isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Peacock isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.